ProfileGDS4718 / 214510_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 53% 56% 73% 55% 50% 55% 50% 55% 52% 54% 53% 51% 51% 49% 52% 53% 51% 49% 44% 49% 56% 54% 49% 51% 55% 48% 52% 52% 47% 49% 45% 48% 57% 52% 49% 51% 53% 51% 52% 74% 56% 47% 44% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6847753
GSM549102patient 115, normal, homogenized [OPG study]5.8753256
GSM549104patient 119, normal, homogenized [OPG study]7.1627573
GSM549108patient 138, normal, homogenized [OPG study]5.8264755
GSM549119patient 077, normal, homogenized [OPG study]5.508950
GSM549133patient 032, cancer, homogenized [OPG study]5.7865755
GSM549139patient 042, cancer, homogenized [OPG study]5.4713450
GSM549099patient 107, normal, homogenized [OPG study]5.8249955
GSM549109patient 139, normal, homogenized [OPG study]5.6308652
GSM549110patient 046, normal, homogenized [OPG study]5.7451454
GSM549114patient 063, normal, homogenized [OPG study]5.6447653
GSM549122patient 082, normal, homogenized [OPG study]5.5598251
GSM549134patient 033, cancer, homogenized [OPG study]5.5365751
GSM549136patient 036, cancer, homogenized [OPG study]5.3903649
GSM549140patient 044, cancer, homogenized [OPG study]5.5804652
GSM549111patient 047, normal, homogenized [OPG study]5.6599953
GSM549113patient 057, normal, homogenized [OPG study]5.524351
GSM549132patient 031, cancer, homogenized [OPG study]5.4622949
GSM549137patient 038, cancer, homogenized [OPG study]5.1779844
GSM549142patient 047, cancer, homogenized [OPG study]5.6058849
GSM549100patient 110, normal, homogenized [OPG study]5.8939856
GSM549107patient 135, normal, homogenized [OPG study]5.7362654
GSM549115patient 068, normal, homogenized [OPG study]5.4067449
GSM549116patient 072, normal, homogenized [OPG study]5.5777651
GSM549120patient 078, normal, homogenized [OPG study]5.7983455
GSM549131patient 030, cancer, homogenized [OPG study]5.3465948
GSM549118patient 074, normal, homogenized [OPG study]5.6248952
GSM549129patient 027, cancer, homogenized [OPG study]5.6455852
GSM549123patient 088, normal, homogenized [OPG study]5.308247
GSM549124patient 006, cancer, homogenized [OPG study]5.5065249
GSM549126patient 015, cancer, homogenized [OPG study]5.2489645
GSM549128patient 025, cancer, homogenized [OPG study]5.3773148
GSM549103patient 117, normal, homogenized [OPG study]5.957157
GSM549117patient 073, normal, homogenized [OPG study]5.555252
GSM549138patient 041, cancer, homogenized [OPG study]5.4584949
GSM549141patient 045, cancer, homogenized [OPG study]5.5292751
GSM549130patient 028, cancer, homogenized [OPG study]5.6816853
GSM549101patient 111, normal, homogenized [OPG study]5.6200551
GSM549105patient 128, normal, homogenized [OPG study]5.6261152
GSM549106patient 134, normal, homogenized [OPG study]7.3550974
GSM549112patient 048, normal, homogenized [OPG study]5.8352456
GSM549125patient 011, cancer, homogenized [OPG study]5.3522847
GSM549127patient 024, cancer, homogenized [OPG study]5.1991644
GSM549135patient 035, cancer, homogenized [OPG study]5.7702755